Adding Ipsilateral V20 and V30 to Conventional Dosimetric Constraints Predicts Radiation Pneumonitis in Stage IIIA-B NSCLC Treated With Combined-Modality Therapy

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 1, 2010, Pages 110-115

  Ramella, Sara ^a   Trodella, Lucio ^a   Mineo, Tommaso Claudio ^b   Pompeo, Eugenio ^b   Stimato, Gerardina ^a   Gaudino, Diego ^a   Valentini, Vincenzo ^c   Cellini, Francesco ^a   Ciresa, Marzia ^a   Fiore, Michele ^a   Piermattei, Angelo ^c   Russo, Patrizia ^d   Cesario, Alfredo ^e,f   D'Angelillo, Rolando M ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e CdC San Raffaele   (Italy)

^f CATHOLIC UNIVERSITY   (Italy)

Author keywords

Dosimetric constraints; Ipsilateral lung; Lung cancer; Pneumonitis; Radiochemotherapy

Indexed keywords

CONCURRENT CHEMORADIATION; CONCURRENT CHEMOTHERAPY; DOSE-VOLUME HISTOGRAMS; IPSILATERAL LUNGS; LUNG CANCER; LUNG VOLUME; MEAN LUNG DOSE; NON SMALL CELL LUNG CANCER; PLANNING TARGET VOLUMES; PULMONARY TOXICITY; RADIATION PNEUMONITIS; RADIOCHEMOTHERAPY; SIGNIFICANT FACTORS; THREE DIMENSIONAL RADIATION; TOTAL DOSE; TREATMENT PLANNING;

CHEMOTHERAPY; DOSIMETERS; DOSIMETRY; FLUORINE CONTAINING POLYMERS; PATIENT MONITORING; RADIOTHERAPY; THREE DIMENSIONAL;

BIOLOGICAL ORGANS;

CISPLATIN; GEMCITABINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; DOSIMETRY; FEMALE; HIGH RISK POPULATION; HISTOGRAM; HUMAN; LUNG NON SMALL CELL CANCER; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION PNEUMONIA; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING; COMPUTER ASSISTED RADIOTHERAPY; LUNG; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIATION DOSE; RADIATION EXPOSURE; REGRESSION ANALYSIS; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; REGRESSION ANALYSIS; RISK ASSESSMENT;

EID: 71949131548     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.01.036     Document Type: Article

References (22)

1. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 (1999) 323-329
2. Hernando M.L., Marks L.B., Bentel G.C., et al. Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51 (2001) 650-659
3. Socinski M.A., Morris D.E., Halle J.S., et al. Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: A dose-escalation phase I trial. J Clin Oncol 22 (2004) 4341-4350
4. Tsujino K., Hirota S., Endo M., et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 55 (2003) 110-115
5. Statement of the American Thoracic Society. Standardization of spirometry-1987 update. Statement of the American Thoracic Society. Am Rev Resp Dis 136 (1987) 1285-1298
6. Trodella L., Granone P., Valente S., et al. Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer. J Clin Oncol 20 (2002) 804-810
7. Galetta D., Cesario A., Margaritora S., et al. Multimodality treatment of unresectable stage III non-small cell lung cancer: Interim analysis of a phase II trial with preoperative gemcitabine and concurrent radiotherapy. J Thorac Cardiovasc Surg 131 (2006) 314-321
8. Belderbos J., Heemsbergen W., Hoogeman M., et al. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol 75 (2005) 157-164
9. Giraud P., and Cosset J.M. Radiation toxicity to the heart: Physiopathology and clinical data [In French]. Bull Cancer 91 (2004) 147-153
10. Trotti A., Colevas A.D., Setser A., et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 (2003) 176-181
11. Kaplan E.M., and Meier P. Non-parametric estimation for incomplete observations. J Am Stat Assoc 53 (1958) 457-481
12. StartXact user manual (1992), Cytel Software, Cambridge, MA p. 521-526
13. Cox D.R. Regression models and life-table. J R Stat Soc 334 (1972) 187-220
14. Rodrigues G., Lock M., D'Souza D., et al. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer-A systematic review. Radiother Oncol 71 (2004) 127-138
15. Armstrong J.C. Target volume definition in 3D conformal radiation therapy of lung cancer. Br J Radiol 71 (1998) 587-594
16. Oetzel D., Schraube P., Hensley F., et al. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 33 (1995) 455-460
17. Seppenwoolde Y., De Jaeger K., Boersma L.J., et al. Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 60 (2004) 748-758
18. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 672-682
19. Willner J., Jost A., Baier K., et al. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy. Strahlenther Onkol 179 (2003) 548-556
20. Gopal R., Tucker S.L., Komaki R., et al. The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys 56 (2003) 106-113
21. Albain K.S., Scott C.B., Rusch V.R., et al. Phase III comparison of concurrent chemotherapy plus radiotherapy (CT/radiotherapy) and CT/radiotherapy followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): Initial results from Intergroup trial 0139 (RTOG 93-09) [Abstract]. Proc Am Soc Clin Oncol 22 (2003) 621
22. Mehta V. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: Pulmonary function, prediction and prevention. Int J Radiat Oncol Biol Phys 63 (2005) 5-24